Diabetic Medicine

Continuous glucose monitoring and closed-loop systems
pp. 1-12(12)
Author: Hovorka, R.

Will ASCOT change the form of anti-hypertensive therapy?
pp. 13-14(2)

Short-term effects of severe dietary carbohydrate-restriction advice in Type 2 diabetes—a randomized controlled trial
pp. 15-20(6)
Authors: Daly, M. E.; Paisey, R.; Millward, B. A.; Eccles, C.; Williams, K.; Hammersley, S.; MacLeod, K. M.; Gale, T. J.

A predictive tool for the self-management of diabetes (Librae): evaluation using a continuous glucose monitoring system
pp. 21-25(5)
Authors: Franklin, V. L.; Wilson, A. W.; Butler, R. A.; Greene, S. A.

Attentional functioning is impaired during acute hypoglycaemia in people with Type 1 diabetes
pp. 26-31(6)
Authors: McAulay, V.; Deary, I. J.; Sommerfield, A. J.; Frier, B. M.

Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications
pp. 32-39(8)
Authors: Lobnig, B. M.; Krömeke, O.; Optenhostert-Porst, C.; Wolf, O. T.

Effect of a pocket-size tablet-dispensing device on glycaemic control in Type 2 diabetic patients
pp. 40-45(6)
Authors: Maier, C.; Mustapic, D.; Schuster, E.; Luger, A.; Eher, R.

Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times
pp. 46-52(7)
Authors: Ashwell, S. G.; Gebbie, J.; Home, P. D.

Angiotensin II does not affect endothelial tone in Type 1 diabetes—results of a double-blind placebo controlled trial
pp. 53-59(7)
Authors: Browne, D. L.; Meeking, D. R.; Allard, S. E.; Munday, J. L.; Shaw, K. M.; Cummings, M. H.

Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy
pp. 60-66(7)
Authors: Scanlon, P. H.; Martin, M. L.; Bailey, C.; Johnson, E.; Hykin, P.; Keightley, S.

Islet autoimmunity and genetic mutations in Chinese subjects initially thought to have Type 1B diabetes
pp. 67-71(5)
Authors: Zhang, D.; Zhou, Z.; Li, L.; Weng, J.; Huang, G.; Jing, P.; Zhang, C.; Peng, J.; Xiu, L.

Common promoter polymorphism in monocyte differentiation antigen CD14 is associated with serum triglyceride levels and body mass index in non-diabetic individuals
pp. 72-76(5)
Authors: Shin, H. D.; Park, K. S.; Park, B. L.; Cheong, H. S.; Cho, Y. M.; Lee, H. K.; Lee, J.-Y.; Lee, J.-K.; Kim, H. T.; Han, B. G.; Kim, J. W.; Koh, I.; Kim, Y. J.; Oh, B.; Kimm, K.; Park, C.

Cross-sectional correlates of fasting hyperinsulinaemia in post-menopausal women of different ethnic origin
pp. 77-85(9)
Authors: Pradhan, A. D.; Manson, J. E.; Hendrix, S. L.; Johnson, K. C.; Wagenknecht, L. E.; Haan, M. N.; Weidner, G.; LaCroix, A. Z.; Cook, N. R.

Insulin pump therapy in childhood diabetes—cost implications for Primary Care Trusts
pp. 86-89(4)
Authors: Feltbower, R. G.; Campbell, F. M.; Bodansky, H. J.; Stephenson, C. R.; McKinney, P. A.

On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes
pp. 90-93(4)
Authors: Schaller, H. C.; Schaupp, L.; Bodenlenz, M.; Wilinska, M. E.; Chassin, L. J.; Wach, P.; Vering, T.; Hovorka, R.; Pieber, T. R.

A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic
pp. 94-98(5)
Authors: Mukhopadhyay, B.; Forouhi, N. G.; Fisher, B. M.; Kesson, C. M.; Sattar, N.

Comparison of microbiological results of needle puncture vs. superficial swab in infected diabetic foot ulcer with osteomyelitis
pp. 99-102(4)
Authors: Kessler, L.; Piemont, Y.; Ortega, F.; Lesens, O.; Boeri, C.; Averous, C.; Meyer, R.; Hansmann, Y.; Christmann, D.; Gaudias, J.; Pinget, M.

The impact of HIV/AIDS on Type 2 diabetes prevalence and diabetes healthcare needs in South Africa: projections for 2010
pp. 103-104(2)

A case of insulin autoimmune syndrome with HLA DRB1*0404: impact on the hypothesis for the molecular pathogenesis involving DRB1 molecules
pp. 104-105(2)

Liver failure in a patient receiving rosiglitazone therapy
pp. 105-106(2)

Diabetes in orld
pp. 107-107(1)

Diabetic Medicine diary
pp. 108-108(1)